G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $683 | -52.0% | 474,080 | -17.1% | 0.00% | -50.0% |
| Q2 2023 | $1,424 | +20.0% | 571,791 | +29.1% | 0.00% | 0.0% |
| Q1 2023 | $1,187 | -66.2% | 442,975 | -31.5% | 0.00% | -60.0% |
| Q4 2022 | $3,514 | -99.7% | 647,100 | +531.9% | 0.01% | +150.0% |
| Q3 2022 | $1,279,000 | -44.2% | 102,400 | -77.9% | 0.00% | -33.3% |
| Q2 2022 | $2,292,000 | -10.2% | 464,000 | +337.3% | 0.00% | 0.0% |
| Q1 2021 | $2,553,000 | +117.5% | 106,100 | +50.1% | 0.00% | +200.0% |
| Q1 2019 | $1,174,000 | +97.0% | 70,700 | +520.2% | 0.00% | 0.0% |
| Q3 2018 | $596,000 | -49.7% | 11,400 | -64.4% | 0.00% | 0.0% |
| Q2 2018 | $1,186,000 | 0.0% | 32,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,186,000 | – | 32,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 719,985 | $31,291,000 | 2.32% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 72,000 | $3,121,000 | 1.20% |
| EMERALD ADVISERS, LLC | 506,424 | $22,009,000 | 0.83% |
| Virtus ETF Advisers LLC | 18,103 | $787,000 | 0.70% |
| Birchview Capital, LP | 22,000 | $956,000 | 0.65% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 352,053 | $15,300,000 | 0.55% |
| Hillhouse Capital Management | 699,431 | $30,397,000 | 0.52% |
| Rock Springs Capital Management LP | 300,000 | $13,038,000 | 0.50% |
| BB BIOTECH AG | 352,607 | $15,324,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 287,000 | $12,473,000 | 0.44% |